1. Home
  2. NAII vs ICCC Comparison

NAII vs ICCC Comparison

Compare NAII & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • ICCC
  • Stock Information
  • Founded
  • NAII 1980
  • ICCC 1982
  • Country
  • NAII United States
  • ICCC United States
  • Employees
  • NAII N/A
  • ICCC N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAII Health Care
  • ICCC Health Care
  • Exchange
  • NAII Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • NAII 28.0M
  • ICCC 28.0M
  • IPO Year
  • NAII 1987
  • ICCC 1987
  • Fundamental
  • Price
  • NAII $4.53
  • ICCC $3.61
  • Analyst Decision
  • NAII
  • ICCC
  • Analyst Count
  • NAII 0
  • ICCC 0
  • Target Price
  • NAII N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • NAII 7.7K
  • ICCC 14.8K
  • Earning Date
  • NAII 11-13-2024
  • ICCC 11-13-2024
  • Dividend Yield
  • NAII N/A
  • ICCC N/A
  • EPS Growth
  • NAII N/A
  • ICCC N/A
  • EPS
  • NAII N/A
  • ICCC N/A
  • Revenue
  • NAII $112,977,000.00
  • ICCC $23,838,002.00
  • Revenue This Year
  • NAII N/A
  • ICCC N/A
  • Revenue Next Year
  • NAII N/A
  • ICCC N/A
  • P/E Ratio
  • NAII N/A
  • ICCC N/A
  • Revenue Growth
  • NAII N/A
  • ICCC 46.37
  • 52 Week Low
  • NAII $4.13
  • ICCC $3.34
  • 52 Week High
  • NAII $7.37
  • ICCC $5.59
  • Technical
  • Relative Strength Index (RSI)
  • NAII 45.33
  • ICCC 50.62
  • Support Level
  • NAII $4.33
  • ICCC $3.38
  • Resistance Level
  • NAII $4.81
  • ICCC $3.81
  • Average True Range (ATR)
  • NAII 0.20
  • ICCC 0.13
  • MACD
  • NAII 0.04
  • ICCC 0.00
  • Stochastic Oscillator
  • NAII 43.40
  • ICCC 53.49

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: